SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001193125-22-243333
Filing Date
2022-09-13
Accepted
2022-09-13 09:08:44
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K/A d331076d6ka.htm   iXBRL 6-K/A 94052
2 EX-99.1 d331076dex991.htm   iXBRL EX-99.1 588203
  Complete submission text file 0001193125-22-243333.txt   3211370

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA obsv-20220630.xsd EX-101.SCH 42476
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE obsv-20220630_cal.xml EX-101.CAL 32465
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE obsv-20220630_def.xml EX-101.DEF 115148
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE obsv-20220630_lab.xml EX-101.LAB 245054
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE obsv-20220630_pre.xml EX-101.PRE 202439
50 EXTRACTED XBRL INSTANCE DOCUMENT d331076d6ka_htm.xml XML 451622
Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Filer) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-37993 | Film No.: 221239821
SIC: 2834 Pharmaceutical Preparations